Development of a risk score for predicting the benefit versus harm of extending dual antiplatelet therapy beyond 6 months following percutaneous coronary intervention for stable coronary artery disease
Table 2
Summary of endpoints by DAPT duration.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Summary of endpoints by DAPT duration.